First approval of inflammation inhibitor in CVD by FDA
This video was recorded in response to the recent decision of the FDA of approving an anti-inflammatory therapy for CVD.
Paul M Ridker is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, USA.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.